EC Number   |
Application |
Reference |
|---|
   3.1.31.1 | analysis |
combined MNase/exoIII digestion can be applied to in situ chromatin for unbiased genome-wide mapping of nucleosome positions that is not influenced by DNA sequences at the core/linker junctions. The same approach can be also used for the precise mapping of the extent of linker DNA protection by H1 and other protein factors associated with nucleosome linkers |
730213 |
| 3.1.31.1 | analysis |
peptide model LMYKGQPM from staphylococcal nuclease can serve as model for faster folding beta-hairpins pursuing fast folding events |
699852 |
| 3.1.31.1 | analysis |
purification of DNA from the cell-associated herpesvirus Marekยs disease virus |
699892 |
| 3.1.31.1 | analysis |
staphylococcal nuclease fused at its N-terminus to signal peptide of the lactococcal Usp45 protein (SP Usp45-NucB), as reporter for expression and secretion in Lactobacillus bulgaricus |
697993 |
| 3.1.31.1 | analysis |
the enzyme is a useful tool for mapping chromatin structure in eukaryotes, usage of the enzyme to determine the positions of nucleosomes within a region of DNA to identify dynamic changes induced during gene regulation |
717620 |
| 3.1.31.1 | analysis |
the enzyme is very widely used to map nucleosomes |
730207 |
| 3.1.31.1 | analysis |
the existence of MNase can be the standard to identify Staphylococcus aureus, and the content of MNase can be used to evaluate the pathogenicity of Staphylococcus aureus, usage of a graphene oxide-based biosensor, method development, overview |
-, 729448 |
| 3.1.31.1 | biotechnology |
co-expression of Staphylococcal nuclease in Escherichia coli to reduce the viscosity of the bioprocess feedstock through auto-hydrolysis of nucleic acids, viscosity is an important physical property of the process stream and a significant factor in the optimization of various downstream processing unit operations including cell disruption, clarification, filtration, and chromatography |
702789 |
| 3.1.31.1 | drug development |
attractive potential target for the development of anti-malarial drugs |
680252 |
| 3.1.31.1 | drug development |
generation of Vibrio anguillarum ghost by coexpression of PhiX 174 Lysis E gene and SNA gene, potential vaccine for fishes against vibriosis |
-, 700123 |
